3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
6
Terminated
2
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Vulvar Neoplasms
2
Ovarian Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Skull Base Neoplasms
1
Gastric Adenocarcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Bone Neoplasms
1
Anastomotic Leak
1
Interventions
Paclitaxel
8
Carboplatin
7
Tirzepatide
3
Observation
3
Cisplatin
3
pembrolizumab
2
dostarlimab
2
Megestrol Acetate
2
Medroxyprogesterone Acetate
2
Blood Specimen Collection
2
trilaciclib
1
toripalimab
1
tislelizumab
1
sintilimab
1
semaglutide
1
olaparib
1
montelukast
1
inavolisib
1
enfortumab vedotin
1
ceralasertib
1
camrelizumab
1
apatinib
1
anlotinib
1
Watchful Waiting
1
Vaginal Smears
1
Topotecan
1
Tablets
1
Specimen Handling
1
Sensitivity Training Groups
1
Resistance Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Endometrial Neoplasms
×
Indocyanine Green
×
Clear all
NCT06871787
2025-03-14
INOCA
Istanbul University
Phase 4
Not yet recruiting
50 enrolled